Hinge Health Statistics
Total Valuation
Hinge Health has a market cap or net worth of $6.11 billion. The enterprise value is $5.71 billion.
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hinge Health has 77.38 million shares outstanding. The number of shares has increased by 110.78% in one year.
| Current Share Class | 54.66M |
| Shares Outstanding | 77.38M |
| Shares Change (YoY) | +110.78% |
| Shares Change (QoQ) | -2.53% |
| Owned by Insiders (%) | 18.36% |
| Owned by Institutions (%) | 67.12% |
| Float | 43.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 28.05 |
| PS Ratio | 9.45 |
| Forward PS | 6.97 |
| PB Ratio | 54.66 |
| P/TBV Ratio | 134.89 |
| P/FCF Ratio | 29.26 |
| P/OCF Ratio | 29.15 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 27.35 |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.30 |
| Quick Ratio | 1.04 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.03 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -136.00% and return on invested capital (ROIC) is -4,157.16%.
| Return on Equity (ROE) | -136.00% |
| Return on Assets (ROA) | -45.74% |
| Return on Invested Capital (ROIC) | -4,157.16% |
| Return on Capital Employed (ROCE) | -167.82% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $449,786 |
| Profits Per Employee | -$355,873 |
| Employee Count | 1,437 |
| Asset Turnover | 0.90 |
| Inventory Turnover | 9.12 |
Taxes
In the past 12 months, Hinge Health has paid $814,000 in taxes.
| Income Tax | 814,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +77.34% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +77.34% |
| 50-Day Moving Average | 56.38 |
| 200-Day Moving Average | 48.25 |
| Relative Strength Index (RSI) | 84.43 |
| Average Volume (20 Days) | 2,362,261 |
Short Selling Information
The latest short interest is 5.77 million, so 7.46% of the outstanding shares have been sold short.
| Short Interest | 5.77M |
| Short Previous Month | 4.21M |
| Short % of Shares Out | 7.46% |
| Short % of Float | 13.37% |
| Short Ratio (days to cover) | 3.40 |
Income Statement
In the last 12 months, Hinge Health had revenue of $646.34 million and -$511.39 million in losses. Loss per share was -$7.27.
| Revenue | 646.34M |
| Gross Profit | 523.41M |
| Operating Income | -527.44M |
| Pretax Income | -509.46M |
| Net Income | -511.39M |
| EBITDA | -525.34M |
| EBIT | -527.44M |
| Loss Per Share | -$7.27 |
Full Income Statement Balance Sheet
The company has $315.87 million in cash and $6.97 million in debt, giving a net cash position of $398.67 million or $5.15 per share.
| Cash & Cash Equivalents | 315.87M |
| Total Debt | 6.97M |
| Net Cash | 398.67M |
| Net Cash Per Share | $5.15 |
| Equity (Book Value) | 311.56M |
| Book Value Per Share | 1.44 |
| Working Capital | 125.58M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $209.60 million and capital expenditures -$740,000, giving a free cash flow of $208.86 million.
| Operating Cash Flow | 209.60M |
| Capital Expenditures | -740,000 |
| Depreciation & Amortization | 2.10M |
| Net Borrowing | n/a |
| Free Cash Flow | 208.86M |
| FCF Per Share | $2.70 |
Full Cash Flow Statement Margins
Gross margin is 80.98%, with operating and profit margins of -81.60% and -78.95%.
| Gross Margin | 80.98% |
| Operating Margin | -81.60% |
| Pretax Margin | -78.82% |
| Profit Margin | -78.95% |
| EBITDA Margin | -81.28% |
| EBIT Margin | -81.60% |
| FCF Margin | 32.31% |
Dividends & Yields
Hinge Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -110.78% |
| Shareholder Yield | n/a |
| Earnings Yield | -8.37% |
| FCF Yield | 3.42% |
Analyst Forecast
The average price target for Hinge Health is $82.07, which is 3.08% higher than the current price. The consensus rating is "Buy".
| Price Target | $82.07 |
| Price Target Difference | 3.08% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 28.93% |
| EPS Growth Forecast (3Y) | 19.09% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hinge Health has an Altman Z-Score of 2.01 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.01 |
| Piotroski F-Score | 3 |